Nurulamin A. Abu Bakar

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3-4 CKD Using the 2021 CKD-EPI Equations.

Multi-Marker Evaluation of Creatinine, Cystatin C and β2-Microglobulin for GFR Estimation in Stage 3-4 CKD Using the 2021 CKD-EPI Equations.

Journal: International journal of molecular sciences

Published: December 09, 2025

Multi-Omics Characterization of a Novel SSR4 Variant in Congenital Disorders of Glycosylation.

Multi-Omics Characterization of a Novel SSR4 Variant in Congenital Disorders of Glycosylation.

Journal: Metabolites

Published: October 22, 2025

Advancement in Clinical Glycomics and Glycoproteomics for Congenital Disorders of Glycosylation: Progress and Challenges Ahead.

Advancement in Clinical Glycomics and Glycoproteomics for Congenital Disorders of Glycosylation: Progress and Challenges Ahead.

Journal: Biomedicines

Published: June 05, 2025

Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.

Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.

Journal: Journal of inherited metabolic disease

Published: August 22, 2021

Effects of prolonged isolation in a confined space on status of oxidative stress and prothrombogenesis: In preparation for possible future manned space expedition to Mars.

Effects of prolonged isolation in a confined space on status of oxidative stress and prothrombogenesis: In preparation for possible future manned space expedition to Mars.

Journal: The Malaysian journal of pathology

Published: January 06, 2020

A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy.

A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy.

Journal: JIMD reports

Published: April 09, 2019

Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.

Sialic acid catabolism by N-acetylneuraminate pyruvate lyase is essential for muscle function.

Journal: JCI insight

Published: May 24, 2018

Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.

Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: March 28, 2018

Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation.

Integrating glycomics and genomics uncovers SLC10A7 as essential factor for bone mineralization by regulating post-Golgi protein transport and glycosylation.

Journal: Human molecular genetics

Published: March 27, 2018

Clinical glycomics for the diagnosis of congenital disorders of glycosylation.

Clinical glycomics for the diagnosis of congenital disorders of glycosylation.

Journal: Journal of inherited metabolic disease

Published: September 18, 2017

Oral D-galactose supplementation in PGM1-CDG.

Oral D-galactose supplementation in PGM1-CDG.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: November 23, 2016

PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.

PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.

Journal: Neuromuscular disorders : NMD

Published: May 21, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026